Gennex Laboratories logo

Gennex Laboratories

GENNEXLABORATORIESLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹264 Cr
Volatility
Moderate
P/E Ratio
13.2
EBITDA
₹21.84 Cr
Return on Equity
9.31%
Debt to Equity
0.36
Book Value
₹9.16
EPS
₹0.58
52W High
₹17.25
52W Low
₹7.05

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company has delivered good profit growth of 34.4% CAGR over last 5 years

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding is low: 23.6%
  • Tax rate seems low
  • Company has a low return on equity of 9.82% over last 3 years.
  • Debtor days have increased from 68.2 to 92.0 days.

Growth Rate

Revenue Growth
16.48% lower than 3Y
Net Income Growth
17.07% lower than 3Y
Cash Flow Change
76.87% higher than 3Y
ROE
24.63% higher than 3Y
ROCE
14.53% lower than 3Y
EBITDA Margin (Avg.)
-34.04% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
16.52
18.18
21.39
35.52
28.32
33.38
40.01
40.33
34.18
39.3
42.96
60.96
39.84
Expenses
11.42
12.41
16.59
29.26
24.1
25.92
32.86
38.31
29.11
31.74
34.39
55.07
35.46
Operating Profit
5.1
5.77
4.8
6.26
4.22
7.46
7.15
2.02
5.07
7.56
8.57
5.89
4.38
OPM %
30.87%
31.74%
22.44%
17.62%
14.9%
22.35%
17.87%
5.01%
14.83%
19.24%
19.95%
9.66%
10.99%
Other Income
0
0
0
0
2.47
0
0
3.68
2.28
0
-0.3
1.02
2.01
Interest
0.73
0.78
0.83
0.73
0.73
0.22
0.84
1.2
0.98
1.03
1.11
1.08
0.57
Depreciation
0.65
1.03
0.45
0.23
0.45
1.11
0.5
0.54
0.5
0.47
0.52
1.16
0.9
PBT
3.72
3.96
3.52
5.3
5.51
6.13
5.81
3.96
5.87
6.06
6.64
4.67
4.92
Tax %
23.39%
22.47%
21.31%
15.28%
15.43%
12.23%
12.91%
22.22%
14.48%
9.08%
9.79%
4.5%
5.08%
Net Profit
2.85
3.07
2.76
4.5
4.66
5.38
5.06
3.07
5.01
5.51
6
4.46
4.67
EPS in Rs
0.16
0.17
0.15
0.2
0.19
0.21
0.2
0.1
0.2
0.21
0.22
0.15
0.18
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
42
44
56
56
60
61
66
87
138
173
183
Expenses
37
42
52
52
53
56
61
70
121
150
157
Operating Profit
5
2
4
3
7
5
5
17
17
22
26
OPM %
11%
5%
7%
6%
11%
9%
7%
20%
12%
13%
14%
Other Income
0
1
1
1
0
1
4
5
10
8
3
Interest
1
1
1
1
1
1
1
3
4
4
4
Depreciation
1
1
1
1
1
1
1
2
2
3
3
PBT
3
1
3
3
5
5
6
16
21
23
22
Tax %
13%
42%
26%
27%
20%
23%
23%
20%
15%
10%
—
Net Profit
3
1
2
2
4
4
5
13
18
21
21
EPS in Rs
0.14
0.04
0.12
0.1
0.21
0.21
0.28
0.58
0.8
0.76
0.76
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
13
13
13
13
13
13
18
23
23
24
Reserves
18
19
21
23
27
31
62
148
164
198
Borrowings
4
2
5
5
7
10
1
6
10
79
Other Liabilities
14
16
13
16
12
14
51
54
59
47
Total Liabilities
49
50
52
57
59
68
132
230
256
349
Fixed Assets
16
16
16
15
14
14
74
56
60
61
CWIP
0
0
0
0
0
0
0
2
5
13
Investments
7
7
7
7
7
7
0
0
0
0
Other Assets
26
28
29
35
38
48
59
172
191
275
Total Assets
49
50
52
57
59
68
132
230
256
349
Figures in ₹ Crores

Cash Flow

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
0
3
2
-2
-1
12
24
-47
-11
-64
Investing
-1
-1
-1
0
0
-2
-38
19
1
-5
Financing
1
-2
1
0
2
-2
21
74
5
65
Net Cash Flow
0
0
2
-2
0
8
6
46
-5
-3
Free Cash Flow
-1
2
1
-2
-2
10
-16
-31
-20
-76
CFO/OP
13
190
55
-52
1
242
505
-274
-45
-274
Figures in ₹ Crores

Ratios

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
90
87
68
41
55
67
52
75
37
92
Inventory Days
43
31
57
78
50
72
139
184
133
153
Days Payable
139
161
88
86
59
72
63
111
49
58
Cash Conversion Cycle
-7
-43
38
34
46
67
129
148
122
187
Working Capital Days
74
75
56
87
108
87
23
255
214
295
ROCE %
—
6%
11%
8%
14%
12%
11%
14%
13%
11%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Gennex Laboratories insights

61 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

Public56.49%Others19.88%Promot.23.63%As ofJun 2026
21.77% of promoter holding pledged as of 10 Sep 2026

Documents

Frequently Asked Questions about Gennex Laboratories

What does Gennex Laboratories Ltd do?
Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]
Where is Gennex Laboratories Ltd (531739) listed?
Gennex Laboratories Ltd trades as GENNEXLABORATORIESLTD on the NSE and under code 531739 on the BSE.
Which sector does Gennex Laboratories Ltd belong to?
Gennex Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Gennex Laboratories Ltd?
Gennex Laboratories Ltd has a market capitalisation of ₹264.28 Cr, which places it in the Small Cap band.
What is the PE ratio of Gennex Laboratories Ltd?
Gennex Laboratories Ltd trades at a PE ratio of 13.20, on earnings per share of ₹0.58, against a book value of ₹9.16 per share.
What is the 52-week high and low of Gennex Laboratories Ltd?
Over the last 52 weeks Gennex Laboratories Ltd has traded between ₹7.05 and ₹17.25.
What is the Return on Equity (ROE) of Gennex Laboratories Ltd?
Gennex Laboratories Ltd reported a return on equity of 9.31%. Its debt-to-equity ratio is 0.36.

Company Information

Incorporated in 1995, Gennex Laboratories Ltd manufactures Bulk Drugs and Intermediaries[1]

Website gennexlab.com
Face Value ₹ 1

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/531739.md for Gennex Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List